Ensemble of hybrid neural network learning approaches for designing pharmaceutical drugs

Neural Computing and Applications

Volumn 16, Issue 3, 2007, Pages 307-316

  Abraham, Ajith ^a   Grosan, Crina ^a,b   Ţigan, Ştefan ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b BABE BOLYAI UNIVERSITY   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Drug design; Ensemble learning; Evolutionary neural network; Hybrid learning; Neuro fuzzy

Indexed keywords

EID: 34547493917     PISSN: 09410643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00521-007-0090-1     Document Type: Article

References (31)

1. Parrill AL (1996) Evolutionary and genetic methods in drug design. Drug Discov Today 1(12):514-521
2. Zoubir AM, Iskander DR (1998) Bootstrap MATLAB Toolbox. Software reference manual
3. Abraham A (2004) Meta-learning evolutionary artificial neural networks. Neurocomp J 56c:1-38
4. Abraham A (2001) Neuro-fuzzy systems: state-of-the-art modeling techniques, connectionist models of neurons, learning processes, and artificial intelligence. In: Mira J, Prieto A (eds.) Lecture notes in computer science. Springer, Berlin, LNCS 2084, pp 269-276
5. Barat A, Ruskin HJ, Crane M (2006) Probabilistic models for drug dissolution. Part 1. Review of Monte Carlo and stochastic cellular automata approaches. Simul Model Pract Theory 14(7):843-856
6. Laghaee A, Malcolm C, Hallam J, Ghazal P (2005) Artificial intelligence and robotics in high throughput post-genomics. Drug Discov Today 10(18):1253-1259
7. Carlsson C, Fullér R (1998) Multiobjective optimization with linguistic variables. In: Proceedings of the sixth European congress on intelligent techniques and soft computing, Aachen, September 7-10, 1998, Verlag Mainz
8. Winkler DA, Burden FR (2004) Bayesian neural nets for modeling in drug discovery. Drug Discov Today: BIOSILICO 2(3):104-111
9. Aradi I, Erdi P (2006) Computational neuropharmacology: dynamical approaches in drug discovery. Trends Pharmacol Sci 27(5):240-243
10. Carpenter J, Goldstein H, Rasbash J (1999) A non-parametric bootstrap for multilevel models. Multilevel Model Newsl 11:2-5
11. Jang SR, Sun CT, Mizutani E (1997) Neuro-fuzzy and soft computing: a computational approach to learning and machine intelligence. Prentice Hall, Englewood Cliffs
12. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151-185
13. Takayama K, Fujikawa M, Obata Y, Morishita M (2003) Neural network based optimization of drug formulations. Adv Drug Deliv Rev 55(9):1217-1231
14. Kennedy J, Eberhart RC (1995) Particle swarm optimization. In: Proceedings of the IEEE international conference on neural networks, Vol. IV, pp 1942-1948. IEEE service center, Piscataway, NJ
15. Stewart KD, Shiroda M, James CA (2006) Drug Guru: a computer software program for drug design using medicinal chemistry rules. Bioorg Med Chem 14(20):7011-7022
16. Hu L, Chen GH, Chau RMW (2006) A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. J Mol Graph Model 24(4):244-253
17. Teroth L, Gasteiger J (2001) Neural networks and genetic algorithms in drug design. Drug Discov Today 6(2):102-108
18. Moller AF (1993) A scaled conjugate gradient algorithm for fast supervised learning. Neural Netw 6:525-533
19. Meek PJ, Liu Z, Tian L, Wang CY, Welsh WJ, Zauhar RJ (2006) Shape signatures: speeding up computer aided drug discovery. Drug Discov Today 11(19-20):895-904
20. Esseiva P, Anglada F, Dujourdy L, Taroni F, Margot P, Pasquier ED, Dawson M, Roux C, Doble P (2005) Chemical profiling and classification of illicit heroin by principal component analysis, calculation of inter sample correlation and artificial neural networks. Talanta 67(2):360-367
21. Burbidge R, Trotter M, Buxton B, Holden S (2001) Drug design by machine learning: support vector machines for pharmaceutical data analysis. Comput Chem 26(1):5-14
22. Câmpean R, Prodan A (2003) Biomatematicǎ - aplicaţii în Excel, Editura Medicalǎ Universitarǎ "Iuliu Haţieganu", Cluj-Napoca, ISBN: 973-693-016-5
23. Câmpean R, Prodan A (2003) A rating model applied for designing drugs. In: Proceedings of the 12-th IASTED international conference on applied simulation and modelling, Marbella, Spain, pp 557-561, ACTA press, ISBN: 0-88986-384-9, ISSN: 1021-8181
24. Agatonovic-Kustrin S, Beresford R (2000) Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal 22(5):717-727
25. Hesterberg T, Monaghan S, Moore DS, Clipson A, Epstein R (2003) Bootstrap methods and permutation tests. W. H. Freeman and Company, New York
26. Solmajer T, Zupan J (2004) Optimization algorithms and natural computing in drug discovery. Drug Discov Today: Technol 1(3):247-252
27. Kiss T, Érdi P (2006) From electric patterns to drugs: perspectives of computational neuroscience in drug design. Biosystems 86(1-3):46-52
28. Sun Y, Peng Y, Chen Y, Shukla AJ (2003) Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 55(9):1201-1215
29. Tang Y, Zhu W, Chen K, Jiang H (2006) New technologies in computer-aided drug design: toward target identification and new chemical entity discovery. Drug Discov Today: Technol 3(3):307-313
30. Grosan C, Abraham A, Tigan S (2006) Engineering drug design using a multi-input multi-output neuro-fuzzy system, 8th International symposium on symbolic and numeric algorithms for scientific computing (SYNASC'06), Timisoara, Romania, IEEE CS Press, pp 365-371
31. Grosan C, Abraham A, Tigan S, Chang T-G, Kim DH (2006) Evolving neural networks for pharmaceutical research, International conference on hybrid information technology (ICHIT'06), IEEE Press, Korea, pp 13-19